Does RISANKIZUMAB-RZAA Cause Headache? 1,554 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,554 reports of Headache have been filed in association with RISANKIZUMAB-RZAA. This represents 2.4% of all adverse event reports for RISANKIZUMAB-RZAA.
1,554
Reports of Headache with RISANKIZUMAB-RZAA
2.4%
of all RISANKIZUMAB-RZAA reports
5
Deaths
239
Hospitalizations
How Dangerous Is Headache From RISANKIZUMAB-RZAA?
Of the 1,554 reports, 5 (0.3%) resulted in death, 239 (15.4%) required hospitalization, and 2 (0.1%) were considered life-threatening.
Is Headache Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 1,554 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Headache?
ADALIMUMAB (19,891)
APREMILAST (17,024)
ETANERCEPT (14,253)
TREPROSTINIL (14,051)
METHOTREXATE (11,718)
TOFACITINIB (11,061)
RITUXIMAB (8,747)
TOCILIZUMAB (8,448)
INFLIXIMAB (8,387)
ABATACEPT (8,184)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Headache Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA